Eph-related receptors and their ephrin ligands are highly conserved protein families which play important roles in targeting axons and migrating cells. In this study we have examined the functional roles of two major autophosphorylation sites, Tyr-615 and Tyr-838, in the EphA8 receptor. Two-dimensional phosphopeptide mapping analysis demonstrated that Tyr-615 and Tyr-838 constitute major autophosphorylation sites in EphA8. Tyr-615 was phosphorylated to the highest stoichiometry, suggesting that phosphorylation at this site may have a physiologically important role. Upon conservative mutation of Tyr-838 located in the tyrosine kinase domain, the catalytic activity of EphA8 was strikingly reduced both in vitro and in vivo, whereas a mutation at Tyr-615 in the juxtamembrane domain did not impair the tyrosine kinase activity. In vitro binding experiments revealed that phosphorylation at Tyr-615 in EphA8 mediates the preferential binding to Fyn-SH2 domain rather than Src and Ras GTPase-activating protein (Ras GAP)-SH2 domains. Additionally, a high level of EphA8 was detected in Fyn immunoprecipitates in intact cells, indicating that EphA8 and Fyn can physically associate in vivo. In contrast, the association of full-length Fyn to EphA8 containing mutation at either Tyr-615 or Tyr-838 was greatly reduced. These data indicate that phosphorylation of Tyr-615 is critical for determining the association with Fyn whereas the integrity of Tyr-838 phosphorylation is required for ecient phosphorylation at Tyr-615 as well as other major sites. Finally, it was observed that cell attachment responses are attenuated by overexpression of wild type EphA8 receptor but to much less extent by EphA8 mutants lacking phosphorylation at either Tyr-615 or Tyr-838. Furthermore, transient expression of kinase-inactive Fyn in EphA8-overexpressing cells blocked cell attachment responses attenuated by the EphA8 signaling. We therefore propose that Fyn kinase is one of the major downstream targets for the EphA8 signaling pathway leading to a modi®cation of cell adhesion, and that autophosphorylation at Tyr-838 is critical for positively regulating the EphA8 signaling event.
Introduction
The Eph family of receptors represents the largest known subfamily of receptor tyrosine kinases (RTKs) and they are activated by cell-surface bound ligands termed ephrins (van der Geer et al., 1994; Eph Nomenclature Committee, 1997) . Eph-related receptors have been classi®ed into two subfamilies, EphA and EphB, depending on their preferential binding to either glycosylphosphatidylinositol (GPI)-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Since ephrins are membrane-bound proteins that appear to require multimerization for full activity (Davis et al., 1994; Stein et al., 1998a) , Eph-ephrin interactions are likely to mediate cell-cell signaling events.
Physiological roles for Eph-related receptors and ephrin ligands have been extensively studied in primary culture systems and using in vivo genetic experiments. Repulsive modes of interaction between Eph receptors and their ligands have been proposed to set up topographic projections in the retinotectal or retinocollicular systems (Cheng et al., 1995; Drescher et al., 1995; Nakamoto et al., 1996; Monschau et al., 1997; Frisen et al., 1998) , the hippocampal and thalamic neurons (Gao et al., 1996 (Gao et al., , 1998 , and the guidance of migrating neural crest cells and motor axons to the rostral halves of developing somites (Krull et al., 1997; Wang and Anderson, 1997) . Abnormalities in the formation of brain commissures have been observed in mice lacking EphB2, EphB3 and EphA8 receptors Orioli et al., 1996; Park et al., 1997) . Although these studies suggest a major function of Eph receptors and their ligands in the neural patterning of the vertebrate nervous system, Eph and ephrin function is also implicated in angiogenesis and vascular network assembly (Pandey et al., 1995b; Stein et al., 1998a; Wang et al., 1998) .
Unlike other RTKs, a two-step mechanism of Eph receptor activation was recently proposed; the ephrin ligand binding is restricted to the amino-terminal globular domain of Eph receptors, whereas the distinct domain in the carboxy-terminal region of the receptor ectodomain mediates ligand-independent receptor-receptor oligomerization leading to receptor transphosphorylation (Lackman et al., 1998) . During the past few years, several immediate downstream targets of Eph receptors have been identi®ed. Several known signaling proteins containing SH2 domains, such as Fyn, Src, and Ras GTPase-activating protein (Ras GAP) have been shown to interact with the conserved tyrosine phosphorylation site in the juxtamembrane domain of Eph receptors (Ellis et al., 1996; Holland et al., 1997; Hock et al., 1998; Zisch et al., 1998) . It has also been reported that direct interaction of EphB1 with the SH2 domain of the adapter protein Nck involves Tyr-594 phosphorylation in EphB1 (Stein et al., 1998b) . Phosphorylated Tyr-929, in the carboxyterminal tail of EphB1, has been shown to associate with the SH2 domain adapter protein Grb10 (Stein et al., 1996) . Interestingly, the equivalent Tyr-929 in EphB1 was required for the recruitment of low molecular weight protein tyrosine phosphatase (LMW-PTP) to receptor complexes upon treatment of multimeric ephrin ligands (Stein et al., 1998a) . Although the interacting tyrosine sites in Eph receptors have not been de®ned yet, Grb2, SLAP, and the regulatory subunit p85 of PI-3 kinase were also implicated as immediate downstream targets for Eph receptors (Pandey et al., 1994 (Pandey et al., , 1995a Stein et al., 1996) . Some studies have indicated that Eph receptors do not exert pronounced mitogenic or transforming activities (Lhotak and Pawson, 1993; Brambilla et al., 1995) . Rather than mediating mitogenic signaling, Eph receptors are likely to regulate the cell cytoskeleton reorganization, on the basis of their biological functions in axon and cell targeting, and further supporting evidence (Meima et al., 1997; Stein et al., 1998a,b) . It remains to be determined how the cytoplasmic targets downstream of Eph receptors regulate the cytoskeleton, leading to axon collapse or cell attachment.
We have previously reported the molecular cloning of a full-length cDNA for mouse EphA8, a member of the EphA subgroup (Park and Sanchez, 1997) . Further studies using mice defective for EphA8 indicated that EphA8 receptors play an important role in axonal path®nding for a subset of tectal commissural axons (Park et al., 1997) . In the present studies, we characterized two major autophosphorylation sites in EphA8. Phosphorylation of Tyr-615 in the juxtamembrane domain mediated a high anity association with the SH2 domain of Fyn both in vitro and in vivo. Phosphorylation of Tyr-838 in the kinase domain was critical for maintaining its catalytic tyrosine kinase activity in an active state, thereby modulating Fyn binding to the Tyr-615 site in the juxtamembrane domain. Functional studies using kinase-inactive Fyn suggest that the recruitment of active Fyn to the activated EphA8 receptor plays an important role in attenuating cell attachment responses. Our ®ndings support a model that Tyr-838 in EphA8 is an important regulatory phosphorylation site determining positive Eph signaling events such as cellular cytoskeletal modi®cations mediated through the Fyn tyrosine kinase.
Results
Tyr-615 and Tyr-838 in EphA8 are highly conserved in all known Eph-related kinases
The Eph-related receptors contain a variable number of tyrosine residues in their cytoplasmic region. Some of these tyrosine residues are highly conserved among all known members of Eph receptor family. Tyr-615 in EphA8 is located in the juxtamembrane domain and all known Eph-related receptors possess the corresponding tyrosine residue in their juxtamembrane domain (Figure 1 ). Previous studies indicated that phosphorylation at this conserved tyrosine residue mediates high anity association with the SH2 domains of either the nonreceptor tyrosine kinases or Ras-GAP (Ellis et al., 1996; Holland et al., 1997; Hock et al., 1998; Zisch et al., 1998) . Interestingly, EphA8 lacks the tyrosine residue corresponding to Tyr-596 in EphA4, which is also highly conserved and may modulate protein binding to its neighboring tyrosine residue (Figure 1 ) (Ellis et al., 1996) .
Tyr-838 is located in the tyrosine kinase domain of the EphA8 receptor and its corresponding tyrosine residues are found in all known members of the Eph family receptors (Figure 1 ). Despite this fact, the functional role of this conserved tyrosine residue has not been determined yet. The ®nding that tyrosine residues corresponding to Tyr-615 and Tyr-838 in EphA8 are highly conserved in all Eph-related receptors suggested to us that phosphorylation of these tyrosine residues may play a pivotal role in the Eph signaling pathway.
Mutation of Tyr-838 in the kinase domain of EphA8 impairs kinase activity
To investigate the functional roles of phosphorylations at Tyr-615 and Tyr-838 in EphA8, the codons for either Tyr-615 or Tyr-838 were substituted with those for phenylalanine within the EphA8 cDNA as described under Materials and methods (Figure 2a ). At the COOH terminus of each EphA8 construct, a 9-amino acid HA epitope was appended to facilitate immunoprecipitation of exogenously expressed EphA8 with an anti-HA antibody. We also generated a rabbit Figure 1 Tyr-615 and Tyr-838 in EphA8 are highly conserved in all Eph-related receptors. The juxtamembrane and tyrosine kinase amino acid sequences of Eph family members are aligned in relation to the Tyr-615 and Tyr-838 residue of EphA8, respectively. The horizontal bar indicates the identical amino acid present in EphA1, with the exception that highly conserved tyrosine residues are indicated in bold type. A small letter representing chick (c), mouse (m), rat (r), and human (h) was included in a parenthesis next to each Eph receptor to indicate their cloning origin polyclonal antibody directed against the juxtamembrane region of the EphA8 receptor, which recognized speci®cally EphA8 but not EphA4 (data not shown). These EphA8 expression constructs were transiently transfected into 293T cells and lysates from each transfected cell line were prepared for immunoprecipitation with anti-HA antibodies. Immunoprecipitates were then assayed by immunoblot using either antiphosphotyrosine antibodies or anti-EphA8 antibodies as probes (Figure 2b ). Similar amounts of HA-tagged EphA8 were present in lysates from cells expressing wild type EphA8, EphA8 F615 , EphA8
F838
and EphA8 F615,838 , respectively, but none was detectable in control cell lysate (Figure 2b , bottom panel). It was evident that both wild type EphA8 and mutant EphA8 containing Phe in the place of Tyr-615 are highly autophosphorylated without further stimulation with exogenous ligands (Figure 2b, To further investigate whether Tyr-615 and Tyr-838 are major autophosphorylation sites in EphA8, we performed phosphopeptide mapping experiments described below. 32 P-labeled EphA8 or EphA8 mutants were isolated, digested with trypsin, and then analysed by two-dimensional peptide mapping using electrophoresis and chromatography on TLC plates ( Figure  4a ). Wild type EphA8 contained ®ve major labeled tryptic phosphopeptides (a, b, b', c and d) as well as a few minor phosphopeptides ( Figure 4a , ®rst panel). Most of the minor phosphopeptides that are variably detected appear to arise from in vitro phosphorylated proteins nonspeci®cally immunoprecipitated by anti-HA antibodies because these phosphopeptides were also observed from the 32 P-labeled control immunoprecipitate lacking the HA-tagged EphA8 receptors ( Figure 3 , lane 1; data not shown). In contrast, EphA8 F615 contained only three major tryptic phosphopeptides (a, c, and d), indicating that both phosphopeptide b and b' include Tyr-615 as a phosphorylation site ( Figure 4a , second panel). Indeed, amino acid sequences¯anking the trypsin cleavage site near to Tyr-615 consists of -Lys-Phe-Pro-Glu-Thr-, which is known to be an inecient cleavage site for trypsin (Boyle et al., 1991) . To further assess which phosphopeptide is a partial cleavage product, phosphopeptide b and b' were separately extracted from TLC plates and then subjected to further digestion with trypsin. These tryptic digests were analysed by one-dimensional chromatography. This data revealed that phosphopeptide b' are further cleaved to produce phosphopeptide b, demonstrating that phosphopeptide b' is a partial cleavage product containing Tyr-615 ( Figure 4b ). Since two major phosphopeptides b and b' contained phosphorylated Tyr-615 residue, Tyr-615 is stoichiometrically the most abundant autophosphorylation site of the EphA8 receptor.
For the EphA8 F838 mutant protein, the phosphopeptide map resembled that of the wild type EphA8 receptor, with the exception that one of the ®ve major was con®rmed by mapping mixes containing similar counts of tryptic digests from wild type EphA8, and EphA8 F838 (data not shown). The presence of additional phosphopeptides a and c indicates that there are at least two additional autophosphorylation sites in EphA8, which were not further characterized for these experiments. The stoichiometry of Tyr-838 phosphorylation was less than that of Tyr-615 phosphorylation, re¯ecting than phosphorylation of Tyr-838 may be unstable. Taken together, these results clearly demonstrate that Tyr-615 in the juxtamembrane domain and Tyr-838 in the kinase domain constitute major autophosphorylation sites of the EphA8 receptor.
EphA8 receptors associate with the SH2 domain of the Fyn kinase
Previous studies indicated that tyrosine phosphorylated Eph-related receptors directly interact with the SH2 domains of either nonreceptor tyrosine kinases or Ras GAP (Ellis et al., 1996; Holland et al., 1997; Hock et al., 1998; Zisch et al., 1998) . To identify the SH2 domains directly interacting with the tyrosine phosphorylated EphA8 receptors, in vitro binding assays were performed using the bacterially expressed GST-SH2 fusion proteins of Fyn, Src, Ras-GAP or the PI-3 kinase p85 subunit. In these experiments, approximately equal amounts of puri®ed Fyn-SH2, Src-SH2, RasGAP-SH2, p85-SH2 or GST alone, were bound to glutathione-Sepharose beads, then mixed with equivalent amounts of lysates prepared from 293 cells stably expressing HA-tagged EphA8. Proteins from the cell lysates that bound to each SH2 fusion protein were recovered with the glutathione-Sepharose beads, and then analysed by immunoblot using anti-EphA8 antibodies as probe (Figure 5a ). Lower molecular weight species, which appear to be degradation products derived from either GST-fusion proteins of EphA8, were variably detected. Nevertheless, these data clearly showed that wild type EphA8 receptors formed a stable complex with the Fyn-SH2 fusion proteins, but not with GST alone (Figure 5a , lanes 1 and 2). It was reproducibly observed that wild type EphA8 bound to the SH2 domain of Fyn with a much higher anity than that of Src ( Figure 5a , lanes 2 and 3). In contrast, for the SH2 domains of either the Ras- Figure 5 (a) A preferential binding of EphA8 to the Fyn-SH2 domain. Approximately equal amounts of puri®ed GST alone, or GST-SH2 fusion proteins of Fyn, Src, Ras-GAP, and p85 subunit of PI-3 kinase, respectively, were bound to glutathione-Sepharose beads and then incubated with equal amounts of lysates from wild type EphA8 expressing 293 cells. Proteins that associated stably with various GST fusion proteins were separated by 7.5% SDS ± PAGE and then probed by anti-EphA8 antibodies for ECL Western blot analysis. The EphA8 receptor bound to the SH2 fusion protein is marked by an arrow. (b) Evidence that phosphorylation at Tyr-615 in EphA8 mediates high anity association with the Fyn-SH2 domain. (Top panel) equivalent amounts of puri®ed Fyn-SH2 fusion proteins were bound to glutathione-Sepharose beads and then incubated with the lysates of 293 cells stably transfected with the indicated expression constructs. The washed beads were separated by 7.5% SDS ± PAGE, and probed on a Western blot with anti-EphA8 antibodies, followed by detection with ECL reagents. (Bottom panel) a fraction of each cell lysate was separately fractionated by SDS ± PAGE and then analysed by immunoblot using anti-EphA8 antibodies as probe GAP or the p85 subunit, the ability to bind to the EphA8 receptor was minimal, compared with the Fyn-SH2 domain (Figure 5a, lanes 4 and 5) . Together, these results demonstrate that, like some members of the Eph-related receptors, the EphA8 receptor is able to form a stable complex with the Fyn-SH2 domain. Similar experiments revealed no stable association with several other SH2-containing proteins, including PLCg, and Lck (data not shown).
Phosphorylation at Tyr-615 in EphA8 mediates association with the Fyn kinase It is likely that phosphorylation at Tyr-615 in EphA8 mediates association with the Fyn kinase, on the basis of the reports that phosphorylation at the corresponding residue in other Eph-related receptors is required for binding to the SH2 domains of nonreceptor tyrosine kinases or Ras-GAP (Ellis et al., 1996; Holland et al., 1997; Hock et al., 1998; Zisch et al., 1998) . The washed beads were assayed by immunoblot using anti-EphA8 antibodies as probe (Figure 5b, top were analysed by immunoblot using either anti-EphA8 antibodies or anti-Fyn antibodies as probes in order to show the relative amounts of EphA8 or Fyn present in those cell lysates prepared for immunoprecipitation (Figure 6b ). Transient expression of kinase-inactive Fyn with a single mutation in the ATP-binding site (Twamley- Stein et al., 1993) in EphA8-expressing cells resulted in 4®ve-fold increase over the endogenous, active protein (Figure 6b , bottom panel, lane 6). Cell lysates were immunoprecipitated with anti-Fyn antibodies and immunoblotted with anti-EphA8 antibodies as probe (Figure 6a) . As expected, a high level of wild type EphA8 was detected in Fyn immunoprecipitates from the cells expressing wild type EphA8 but not parental cells (Figure 6a, lanes 1 and 2) , the ability to bind full-length Fyn was abolished (Figure 6a , lanes 3, 4, and 5). The kinase-inactive Fyn protein retained its ability to associate with the EphA8 receptor ( Figure  6a, lane 6 ). These data demonstrate that phosphorylation at Tyr-615 in EphA8 mediates association with the Fyn kinase in vivo. Furthermore, our data indicate that constitutive phosphorylation at Tyr-838 in the kinase domain is required to mediate the association of signaling proteins such as Fyn by escalating phosphor- Figure 6 (a) Evidence that phosphorylation at Tyr-615 in EphA8 is critical for stable association with the full-length Fyn kinase in intact cells. Proteins from each cell lysate were immunoprecipitated with anti-Fyn antibodies and then analysed by immunoblot using anti-EphA8 antibodies as probe. For expression of kinaseinactive Fyn (Lys-299?Met), the pcDNA3-derived expression plasmids were transiently transfected into the EphA8-expressing 293 cells using LipofectAMINE and then cells were lysed 48 h after transfection. ylation at Tyr-615 in the juxtamembrane domain of EphA8.
Activation of the EphA8 receptor attenuates cell attachment
The roles for Eph receptors and their ligands in cell-cell repulsion have been well established (Drescher et al., 1995; Nakamoto et al., 1996; Monschau et al., 1997; Frisen et al., 1998) . To investigate whether the EphA8 signaling aects cell adhesion, the same cell lines used for demonstrating Fyn association in vivo were tested for their properties to attach to culture dishes. After seeding the equivalent numbers of each cell line, the plates were washed with PBS after 60 min and the fraction of attached cells were calculated. In multiple experiments, cells expressing a high level of the wild type EphA8 receptor showed a signi®cant reduction of cell attachment, whereas the attachment responses of cell lines expressing EphA8 F615 , EphA8 F838 or EphA8 F615,838 were reduced to a much less extent (Figure 6c ). Furthermore, co-expression of kinaseinactive Fyn with EphA8 resulted in marked increases in cell attachment, suggesting that the kinase-inactive form of Fyn competed for the binding site for endogenous Fyn and possibly other non-receptor tyrosine kinases on the activated EphA8 receptor. Similar experiments were carried out using two additionally independent clones expressing wild type EphA8, which gave virtually identical results (data not shown). Together, our ®ndings suggest that the EphA8 signaling interferes with the adhesive properties of the cells through the Fyn signaling.
Discussion
In this report, we examined the major sites of tyrosine phosphorylation of EphA8 as well as its interactive SH2 partners. Tryptic peptide mapping analyses of various EphA8 mutants from in vitro kinase reactions established that Tyr-615 and Tyr-838 in EphA8 constitute major autophosphorylation sites. The lack of phosphorylation at Tyr-838 located in the kinase domain of EphA8 impaired the kinase catalytic activity. In contrast, the enzymatic activity of EphA8 containing Phe at the place of Tyr-615 was not signi®cantly impaired. Like some other Eph-related receptors, phosphorylation at Tyr-615 in the juxtamembrane domain of the EphA8 receptor was critical for strong association with the Fyn kinase in a manner dependent of the SH2 domain. Furthermore, inecient phosphorylation at Tyr-615 due to the lack of Tyr-838 phosphorylation resulted in a great reduction of Fyn association to EphA8. 293 cells are likely to express endogenous ligands for the EphA8 receptor since the extracellular domain of EphA8 binds to the parental 293 cells with a signi®cant anity (data not shown). This is consistent with the result that the EphA8 receptors expressed in 293 cells are constitutively tyrosine-phosphorylated. Moreover, tyrosine phosphorylation status of EphA8 in 293 cells was not signi®cantly altered by further treatment of exogenous ephrin ligands regardless of being clustered by anti-Fc antibody. Interestingly, the capacity of the extracellular domain of EphA8 to bind the parental 293 cells was not altered by the treatment of PI-PLC, possibly due to modi®cation of GPI-anchors in 293 cells. Nevertheless, our results based on the constitutive tyrosine phosphorylation processes in 293 cells are in a good agreement with the notion that phosphorylation of tyrosines within the catalytic domain is essential for maintaining the tyrosine kinase in an active state, whilst tyrosine phosphorylation in noncatalytic regions leads to generation of docking sites for SH2 or PTB domains of signaling molecules (van der Geer et al., 1994; Schlessinger et al., 1997) .
The data presented here provide the ®rst characterization of an autophosphorylation site, Tyr-838, conserved in all Eph-related receptors. Our phosphopeptide mapping analysis indicated that the stoichiometry of Tyr-838 phosphorylation is less than that of Tyr-615 phosphorylation. This may re¯ect that phosphorylation of Tyr-838 may be unstable during the preparation of phosphopeptides. Alternatively, Tyr-838 may be highly phosphorylated sites in intact cells and not be subject to incorporation of label. Initially, the motif YWNM containing Tyr-838 led us to investigate whether phosphorylation at this site mediates the association with the p85 subunit SH2 domain of PI-3 kinase. Although EphA8 bound to the p85 subunit SH2 domain at a low level, this interaction was not dependent on the phosphorylation at Tyr-838 (unpublished data). Recently, it was proposed that the Eph receptor activation takes place in a two-step mechanism with distinct ligand binding domain and ligand independent receptor-receptor oligomerization events (Lackmann et al., 1998) . Likewise, transphosphorylation of Eph receptors may occur in a stepwise mechanism, in a way that Tyr-838 is primarily phosphorylated to maintain the kinase domain in an active state. Our ®nding that Tyr-838 in EphA8 is critical for the tyrosine kinase activity also suggests that this tyrosine residue may be an important autoregulatory site for Eph signaling pathway. For instance, dephosphorylation at Tyr-838 by yet unknown tyrosine phosphatase would lead to an inactive state of the kinase domain, thereby turning o the signal transduction. Interestingly, it was reported that EphB1 receptor complexes recruit low molecular weight phosphotyrosine phosphatase (LMW-PTP) upon treatment with multimeric ligands (Stein et al., 1998a) . It will be interesting to examine whether LMW-PTP is able to eliminate phosphorylation at Tyr-838 in EphA8.
Our ®nding that Tyr-615 in the juxtamembrane domain of EphA8 is the most abundant autophosphorylation site and also the predominant binding site for Fyn suggests that the signaling mechanism of EphA8 is similar to that of EphA4. However, EphA8 does not possess the tyrosine residue corresponding to Tyr-596 in EphA4, which is another juxtamembrane autophosphorylation site conserved in most Ephrelated receptors. It has been postulated that phosphorylation at Tyr-596 plays an important role in modulating Fyn binding to the Tyr-602 site of EphA4, the residue corresponding to Tyr-615 in EphA8, since mutation of Tyr-596 to Phe led to a reduction in stable association between EphA4 and Fyn (Ellis et al., 1996) . Other studies also indicated that phosphorylation of the tyrosine residue corresponding to Tyr-596 in EphA4 creates the formation of a Nck docking site in EphB1 (Stein et al., 1998b) . The absence of the corresponding tyrosine residue in EphA8 suggests that phosphorylation of Tyr-615 is sucient to create a high anity binding motif for Fyn at least in the case of the EphA8 receptor. It remains to be determined whether, in addition to Tyr-615, there are other sites in EphA8 to which Fyn-SH2 domain binds since the EphA8 F838 mutant retains the capacity to bind the Fyn-SH2 domain albeit the greatly reduced endogenous tyrosine kinase activity of EphA8. Unlike EphB2 and other Eph-related receptors, phosphorylation at Tyr-615 in EphA8 resulted in the preferential recruitment of Fyn, rather than Src and Ras-GAP, to signaling pathway of these receptors. It is not clear how the SH2 domains of nonreceptor tyrosine kinases discriminate between Eph receptors, but it is likely that additional nonconserved amino acids, in addition to the sequence motif identi®ed as the key site of interaction may provide the speci®city observed. It was recently proposed that the sequence divergence at position +5 relative to Tyr-614 in EphB3, the site corresponding to Tyr-615 in EphA8, might be crucial for determining the binding properties of Ras-GAP (Hock et al., 1998) . For instance, the presence of an acidic amino acid such as glutamic or aspartic acid at position +5 determined the binding anity to the amino-terminal SH2 domain of Ras-GAP as demonstrated in the cases of EphB1 and EphB3. Like EphA4, our data is in a good agreement with this ®nding as the nonconservative arginine residue at position +5 relative to the Tyr-615 in EphA8 was consistent with the result that Ras-GAP SH2 weakly bound to the EphA8 receptor in an in vitro binding experiment.
It seems that the association between EphA8 and Fyn is very stable in intact cells since it withstands stringent detergent buer conditions such as 1% Triton X-100. Furthermore, the adhesive properties of the cells were attenuated in a good correlation with the kinase activity and Fyn association. Dominant negative approach using kinase-inactive Fyn revealed that the Fyn signaling plays an important role in linking EphA8 signaling to cell attachment responses. It is unlikely that phosphorylation at Tyr-615 in EphA8 is mediated by the cellular Fyn kinase associating with EphA8 since tyrosine phosphorylation status of EphA8 in cells transfected with the kinase-inactive Fyn mutant was not altered (data not shown). Our data on EphA8 function on cell adhesion appear contradictory to previous reports indicating that activation of Eph receptors promotes cell attachment response in endothelial-or teratocarcinoma-derived cell lines (Stein et al., 1998a,b) . These dierences may re¯ect the cell adhesion properties of the dierent cell-types used. Consistent with our data, ectopic expression of EGFR-XEphA4 chimeric receptor in Xenopus embryos induces dissociation of embryonic tissues, suggesting that the Eph signaling interferes with cell adhesion (Winning et al., 1996) . We therefore propose that Fyn is the principal target of the EphA8 receptor in the signal transduction leading to the modulation of the cytoskeletal architecture of the epithelial cells or possibly neuronal cells. Fyn in the brain is localized in the developing axonal tracts as well as subpopulations of adult neurons and glia (Ingraham et al., 1992; Bare et al., 1993; Yagi et al., 1993a Yagi et al., , 1994 . Additional studies on fyn knock-out mice reveals defects in long term potentiation, spatial learning, hippocampal development, and myelination (Grant et al., 1992; Yagi et al., 1993b; Umemori et al., 1994) . Our previous studies using ephA8 7/7 mice indicated that EphA8 receptors play an important role in axonal path®nding for a subset of tectal commissural axons (Park et al., 1997) . Many other studies also indicated that the interaction between Eph receptors and their corresponding ligands in neuronal cells regulate growth cone motility or axon fasciculation, rather than cell proliferation (Orioli and Klein, 1997) . Therefore, Fyn may represent the functional link between the EphA8 receptor and the downstream signaling proteins that regulate these neuronal processes. The determination of how the EphA8 and Fyn signaling regulates the cell cytoskeleton in vivo requires additional experiments, including actin ®lament staining and characterization of focal adhesion or cell adhesion proteins. Nevertheless, our data on the functional roles of major tyrosine phosphorylation sites in EphA8 should facilitate further studies directed toward how the EphA8 receptors supports the development of the neuronal cells in the brain.
Materials and methods

Cell culture and transfection
293T cells were maintained in a humidi®ed atmosphere of 5% CO 2 at 378C in Dulbecco's modi®ed Eagle's medium (Sigma) supplemented with 10% heat-inactivated fetal bovine serum. 293 cells were routinely cultured in alpha-MEM (Sigma) containing 10% heat-inactivated fetal bovine serum. For stable transfection with pcDNA3-derived expression plasmids, the calcium phosphate precipitation method was used as described previously (Graham and van der Eb, 1973) . Stable G418-resistant clones were selected by supplementing the culture medium with 250 mg/ml G418. The clones were periodically cultured in the same selection medium to maintain stable expression. For transient transfections, cells were transfected using LipofectAMINE (Life Technologies, Inc) as described by the manufacturer.
Construction of HA-tagged EphA8
To introduce the 9 amino acid HA epitope (YPYDVPDYA) at the COOH terminus of murine EphA8, two PCR oligomers were synthesized. A 58-base pair oligonucleotide consisted of the extreme 3' end 18 bp nucleotides of the ephA8 coding sequence, the HA tag sequence, a TAA stop codon, and a SalI site at the 3' end. A 20 bp oligonucleotide corresponded to nucleotides 2833 ± 2852 of the murine ephA8 coding sequence. PCR using these amplimers was performed with Taq polymerase (Boehringer Mannheim) to amplify 218 bp DNA fragments. The PCR products were further digested with BssHII and SalI and the isolated DNA fragment was subcloned into full-length ephA8 in pcDNA3. DNA sequencing in the region of the polymerase chain reaction was performed to exclude the possibility of errors by the polymerase.
To introduce phenylalanine at the place of tyrosine, site directed mutagenesis was performed using Altered Sites II in vitro mutagenesis systems (Promega). First, a 2134 bp XhoI fragment of murine ephA8 cDNA containing the codons for both Tyr-615 and Tyr-838 was isolated and subcloned into the SalI site of pAlter-I vector (Promega). To introduce a point mutation at the Tyr-615 codon, a 20 bp oligonucleotide (nucleotides 1833 ± 1852 of the ephA8 coding sequence) incorporating TTT (Phe) instead of TAT (Tyr-615) was used together with amp repair and tet knock-out oligonucleotides, according to the manual. The point mutation at the Tyr-838 codon was generated using a 20 bp oligonucleotide (nucleotides 2503 ± 2522 of the ephA8 coding sequence) incorporating TTT (Phe) instead of TAT (Tyr-838). The resulting inserts containing Phe-615 or Phe-838 codon were digested with NheI and EcoRI, and the isolated 1964-bp fragments were subcloned into the corresponding region of full-length ephA8 in pcDNA3 vector. To generate the fulllength EphA8 F615,F838 construct, a 1976 bp EcoRI and BamHI fragment containing the Phe-615 codon was subcloned into the EcoRI site of pcDNA3 together with a 1269 bp BamHI and EcoRI fragment containing the Phe-838 codon.
Immunoprecipitation and immunoblotting
Con¯uent 10 cm plates of cells were washed two times with cold phosphate-buered saline containing 1 mM sodium orthovanadate and then lysed in 1 ml of cold PLC lysis buer (50 mM HEPES, pH 7.5, 150 mM NaCI, 10% glycerol, 1% Triton X-100, 1.5 mM MgCI 2 , 1 mM EGTA, 10 mM sodium pyrophosphate, 100 mM sodium¯uoride, 20 mg/ml Aprotinin, 1 mM PMSF, and 1 mM sodium orthovanadate). Lysates were clari®ed by centrifugation in a microcentrifuge for 15 min at 48C, and then incubated with the indicated antibodies for 1 h on ice. Protein A-Sepharose (Pharmacia) was then added for 30 min, and immunoprecipitates were washed three times by pelleting in a cold HNTG buer (20 mM HEPES, pH 7.5, 150 mM NaCl, 0.1% Triton X-100, 10% glycerol, and 1 mM sodium orthovanadate). For GSTmixing experiments, 5 mg of fusion proteins were immobilized on glutathione-Sepharose beads and then mixed with cell lysates for 1 h at 48C. Then, proteins bound to the beads were washed three times by pelleting in cold HNTG buer.
Immunoprecipitates were boiled in SDS-sample buer, loaded on 7.5% or 10% SDS-polyacrylamide gels and separated by electrophoresis. Proteins resolved by SDS ± PAGE were electrophoretically transferred to Immobilon-P (Millipore) membranes. Membranes were blocked in TN-TX buer (50 mM Tris-HCl, pH 7.5, 200 mM NaCl, 0.2% Triton X-100) containing 3% BSA (for anti-phosphotyrosine antibody blots) or skimmed milk and immunoblotted according to standard protocols. Detection of primary antibodies was performed using horseradish peroxidase-conjugated donkey anti-rabbit IgG or anti-mouse IgG followed by Enhanced Chemiluminescence (Amersham).
In vitro labeling and phosphopeptide mapping analysis
For in vitro phosphorylation of EphA8, immunoprecipitates described above were washed two times in cold HNTG buer and two times in kinase reaction buer (20 mM HEPES, pH 7.5, 2.5 mM MgCl 2 , 4 mM MnCl 2 , 1 mM sodium orthovanadate). The washed beads were incubated in 50 ml of kinase reaction buer with 5 mCi of [g-32 P]ATP (NEN) for 30 min at room temperature. Unincorporated ATP was removed by washing 2 ± 3 times in cold HNTG buer. For the enolase assay, 5 mg of acid-denatured enolase (Cooper et al., 1984) was added to the kinase reaction, incubated for 30 min at room temperature, and the whole reaction was loaded on the gel. The labeled proteins were resolved by SDS ± PAGE, and dried gels were autoradiographed for 30 min at room temperature.
For phosphopeptide mapping analysis, labeled proteins separated by SDS ± PAGE were transferred to Immobilon-P membranes and then localized by autoradiography. Immobilized proteins were directly digested with TPCK-trypsin (20 mg) by incubating membrane pieces in 50 mM NH 4 HCO 3 , pH 7.5 at 378C for 4 h. Tryptic peptides were then analysed by electrophoresis in pH 1.9 buer (®rst dimension) and chromatography in regular buer (second dimension) on TLC plates as described (Boyle et al., 1991) . To elute the phosphate-containing peptides from TLC plates, the areas on TLC plates were aspirated using 1-ml blue tips plugged by polyethylene matrix and eluted in pH 1.9 buer.
Cell attachment assays
Cells were collected by brief trypsinization, washed once with the complete medium (alpha-MEM containing 10% heatinactivated fetal bovine serum) and then plated at 5610 5 cells per 35-mm plate without coating. After 60 min, unattached cells were collected and combined with the remaining unattached cells recovered by washing once with phosphatebuered saline containing calcium and magnesium. The attached cells were collected by brief trypsinization after an additional 60 min and the viable cells were counted. The ratio of attached to total number of cells recovered was calculated.
Antibodies
Polyclonal rabbit antisera speci®c for the juxtamembrane domain of EphA8 were raised by injection of rabbits with the GST fusion proteins puri®ed from E. coli culture. To generate a GST-juxtamembrane fusion protein expression vector, a 233 bp PCR ampli®ed DNA fragment, corresponding to the nucleotides 1684 ± 1916 of the ephA8 coding sequence, was subcloned into the GST-fusion vector pGEX-5X-1 (Pharmacia). Monoclonal anti-phosphotyrosine antibodies (4G10) and polyclonal rabbit anti-Fyn antibodies (raised against amino acid 35 ± 51 of human Fyn) were purchased from Upstate Biotechnology (Lake Placid, NY, USA). Polyclonal rabbit anti-HA antibodies were obtained from either Zymed Laboratories Inc. (San Francisco, CA, USA) or Santa Cruz Biotechnology (Santa Cruz, CA, USA).
